Low E-Health Record Adoption Presents Challenge For R&D Use, AstraZeneca Informatics Scientist Says
Executive Summary
Adoption of EHRs “is not where it should be” to make them a valuable part of the drug R&D process, but progress is being made, according to AstraZeneca informatics scientist Sergio Eslava.